BETHESDA, Md--The American Medical Writers Association is accepting applications for the 1997 Rose Kushner Awards for Writing Achievement in the Field of Breast Cancer. A cash award of $1,000 for the winning entry in each of five categories will be provided through a grant from Zeneca Pharmaceuticals.
BETHESDA, Md--The American Medical Writers Association is acceptingapplications for the 1997 Rose Kushner Awards for Writing Achievement inthe Field of Breast Cancer. A cash award of $1,000 for the winning entryin each of five categories will be provided through a grant from ZenecaPharmaceuticals.
The awards were established in 1990 as a memorial tribute to Rose R.Kushner, a former member of the Association and a pioneer in breast cancereducation and patient advocacy. A survivor of breast cancer for 16 years,Rose Kushner died on January 7, 1990, at the age of 60.
Award categories include published lay articles (newspapers or magazines),published scientific articles (journals), brochures and monographs, books(medical and lay audiences), and scripts for video, film, or radio (medicaland lay audi-ences). Entries must have been published or shown from March1996 through March 1997.
The competition is open to AMWA and non-AMWA members. Entries may besubmitted by persons other than the writer, but the award, presented atthe AMWA Annual Conference, goes only to the writer.
The deadline for entries is May 10, 1997. For more information, contactthe American Medical Writers Association, 9650 Rockville Pike, Bethesda,MD 20814-3998. Telephone: 301-493-0003; Fax: 301-493-6384.
Stay up to date on recent advances in the multidisciplinary approach to cancer.
The Proper Ways to Identify and Use ADCs in Breast Cancer Subtypes
June 29th 2025Deciding when to use immunotherapy and how to utilize antibody-drug conjugates are complicated processes that require multidisciplinary collaboration to ensure that all patients with breast cancer receive appropriate and efficient care.
Cardio-Oncology Considerations for Breast Cancer: Risk Stratification, Monitoring, and Treatment
June 26th 2025Survivors of breast cancer face increased cardiovascular risks due to treatment-related cardiotoxicity, and understanding these risks is crucial for effective management and prevention.